| Literature DB >> 15628601 |
L D Smirnov, V I Inchina, Ia V Kostin, E V Kokoreva, Zh V Bogoliubova.
Abstract
On model of experimental diabetes in rats the possibility of correction of impairments of lipid, carbohydrate and albumin metabolism by SEMOP in a dose of 25 or 5 mg/kg, dimephosphone (100 mg/kg) and alpha-tocopherol (25 mg/kg) has been Advantage of SEMOP consists in its ability to decrease a level of total protein and albumin of blood of animals with experimental diabetes.Entities:
Mesh：
Substances：
Year: 2004 PMID： 15628601
Source DB: PubMed Journal: Biomed Khim ISSN： 2310-6905